PortfoliosLab logo
PortfoliosLab logo
Tools
Portfolios
Screeners
Discussions
BPLEX vs. CLSE
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between BPLEX and CLSE is 0.73, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.

BPLEX vs. CLSE

Last updated May 31, 2025

Compare and contrast key facts about Boston Partners Long/Short Equity Fund (BPLEX) and Convergence Long/Short Equity ETF (CLSE).

BPLEX is managed by Boston Partners. It was launched on Nov 16, 1998. CLSE is an actively managed fund by Convergence Investment Partners. It was launched on Feb 22, 2022.

Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BPLEX or CLSE.

Performance

BPLEX vs. CLSE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Boston Partners Long/Short Equity Fund (BPLEX) and Convergence Long/Short Equity ETF (CLSE). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

BPLEX:

1.15

CLSE:

0.67

Sortino Ratio

BPLEX:

1.54

CLSE:

0.84

Omega Ratio

BPLEX:

1.22

CLSE:

1.12

Calmar Ratio

BPLEX:

1.28

CLSE:

0.58

Martin Ratio

BPLEX:

5.31

CLSE:

1.75

Ulcer Index

BPLEX:

2.58%

CLSE:

5.46%

Daily Std Dev

BPLEX:

12.76%

CLSE:

16.18%

Max Drawdown

BPLEX:

-43.47%

CLSE:

-16.45%

Current Drawdown

BPLEX:

-0.92%

CLSE:

-4.78%

Returns By Period

In the year-to-date period, BPLEX achieves a 6.01% return, which is significantly higher than CLSE's 0.09% return.

BPLEX

YTD

6.01%

1M

2.65%

6M

0.96%

1Y

14.54%

3Y*

11.36%

5Y*

15.82%

10Y*

7.70%

CLSE

YTD

0.09%

1M

5.04%

6M

-1.75%

1Y

10.70%

3Y*

14.53%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Boston Partners Long/Short Equity Fund

Convergence Long/Short Equity ETF

BPLEX vs. CLSE - Expense Ratio Comparison

BPLEX has a 2.21% expense ratio, which is higher than CLSE's 1.56% expense ratio.

BPLEX
Boston Partners Long/Short Equity Fund
CLSE
Convergence Long/Short Equity ETF
Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

BPLEX vs. CLSE — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
BPLEX
The Risk-Adjusted Performance Rank of BPLEX is 8282
Overall Rank
The Sharpe Ratio Rank of BPLEX is 7878
Sharpe Ratio Rank
The Sortino Ratio Rank of BPLEX is 7979
Sortino Ratio Rank
The Omega Ratio Rank of BPLEX is 8181
Omega Ratio Rank
The Calmar Ratio Rank of BPLEX is 8585
Calmar Ratio Rank
The Martin Ratio Rank of BPLEX is 8585
Martin Ratio Rank
CLSE
The Risk-Adjusted Performance Rank of CLSE is 5252
Overall Rank
The Sharpe Ratio Rank of CLSE is 5757
Sharpe Ratio Rank
The Sortino Ratio Rank of CLSE is 4848
Sortino Ratio Rank
The Omega Ratio Rank of CLSE is 5050
Omega Ratio Rank
The Calmar Ratio Rank of CLSE is 5959
Calmar Ratio Rank
The Martin Ratio Rank of CLSE is 4949
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BPLEX vs. CLSE - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Boston Partners Long/Short Equity Fund (BPLEX) and Convergence Long/Short Equity ETF (CLSE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current BPLEX Sharpe Ratio is 1.15, which is higher than the CLSE Sharpe Ratio of 0.67. The chart below compares the historical Sharpe Ratios of BPLEX and CLSE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

BPLEX vs. CLSE - Dividend Comparison

BPLEX's dividend yield for the trailing twelve months is around 27.70%, more than CLSE's 0.92% yield.

TTM20242023202220212020201920182017201620152014
BPLEX
Boston Partners Long/Short Equity Fund		27.70%29.36%28.35%15.19%5.11%44.84%11.33%9.69%0.83%0.00%9.91%9.61%
CLSE
Convergence Long/Short Equity ETF		0.92%0.93%1.21%0.85%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

BPLEX vs. CLSE - Drawdown Comparison

The maximum BPLEX drawdown since its inception was -43.47%, which is greater than CLSE's maximum drawdown of -16.45%. Use the drawdown chart below to compare losses from any high point for BPLEX and CLSE.

Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

BPLEX vs. CLSE - Volatility Comparison

Boston Partners Long/Short Equity Fund (BPLEX) has a higher volatility of 2.84% compared to Convergence Long/Short Equity ETF (CLSE) at 2.39%. This indicates that BPLEX's price experiences larger fluctuations and is considered to be riskier than CLSE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading data...